Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Translational Lung Cancer Research|February 11, 2021
Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancerMasashi Ishihara, Ryosuke Ochiai, Terunobu Haruyama, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 2008
Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapyShuji Ota, Genichiro Ishii, Koichi Goto, et al.Case Reports in Oncology|February 13, 2018
A Case of Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Improved by ChemotherapyTakahiko Sakamoto, Shuji Ota, Terunobu Haruyama, et al.Case Reports in Oncology|March 9, 2018
A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and PemetrexedMaika Natsume, Takeshi Honda, Terunobu Haruyama, et al.Case Reports in Oncology|March 9, 2018
A Patient with Advanced Gastric Cancer Who Achieved a Long-Term Prognosis by Early Diagnosis of Sister Mary Joseph's NoduleShuji Ota, Terunobu Haruyama, Masashi Ishihara, et al.Internal Medicine (Tokyo, Japan)|December 28, 2017
Paraneoplastic IgA Vasculitis in an Adult with Lung AdenocarcinomaShuji Ota, Terunobu Haruyama, Masashi Ishihara, et al.Case Reports in Oncology|February 23, 2019
Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin RushNobuhiko Seki, Ryosuke Ochiai, Terunobu Haruyama, et al.Case Reports in Oncology|February 13, 2018
A Case of Advanced Submandibular Gland Cancer in Which Increased Prostate-Specific Antigen and Multiple Bone Metastases Wrongly Suggested Concurrent Prostate CancerYoko Fukasawa, Takeshi Honda, Maika Natsume, et al.Case Reports in Oncology|February 23, 2019
Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI TherapyNobuhiko Seki, Maika Natsume, Ryosuke Ochiai, et al.Case Reports in Oncology|February 23, 2019
Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature ReviewShuji Ota, Takahiko Sakamoto, Ryosuke Ochiai, et al.Pageof 3